Lung Cancer
Conditions
Interventions
Control group:Routine support, rehabilitation, physical therapy
Experimental group:Routine support, rehabilitation, physical therapy +Fufang Bufei Decoction
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Primary lung cancer patients undergoing surgical treatment; (2) The age range for signing an informed consent form is between 18 and 75 years old (including the threshold); (3) Subjects voluntarily participate in clinical studies; Fully understand and be aware of this study and sign an informed consent form willing to follow and capable of completing all trial procedures.
Exclusion criteria
Exclusion criteria: (1) Preoperative moderate to severe cough or long-term use of steroids bronchodilators and antibiotics within 15 days; (2) Subjects with unstable vital signs or complications such as bleeding severe infection electrolyte disorders and severe damage to other organs; (3) Within 5 years or simultaneously suffering from other active malignant tumors; (4) Have participated in any other intervention clinical trials within 28 days prior to the administration of this trial; (5) Subjects who have undergone other major surgeries other than diagnosis or biopsy within 28 days prior to the first administration or who will undergo other major surgeries during the study period; (6) Failure to recover from adverse events caused by any intervention measures prior to initial administration; (7) Individuals who are allergic to the drugs used in this study; (8) Patients with severe functional impairments in the heart liver and kidneys; (9) Pregnant or lactating women; (10) There is a medical history or disease (such as interstitial pneumonia moderate to severe COPD) that may interfere with the trial results hinder the full participation of the subjects in the study treatment or laboratory abnormalities or the researchers believe that participating in the study is not in the best interests of the subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of postoperative cough in lung cancer patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function;kidney function;Anxiety and Depression Scale;routine blood test;albumin;Traditional Chinese Medicine Symptom Survey Form;Quality of Life Scale; | — |
Countries
China
Contacts
Public ContactChe Guowei
West China Hospital of Sichuan University
Outcome results
None listed